期刊文献+

3'-氨基-2'-羟基联苯-3-羧酸的合成 被引量:3

Synthesis of 3'-Amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic Acid
原文传递
导出
摘要 2-硝基-6-溴苯酚经苄基保护后得2-苄氧基-1-溴-3-硝基苯,再和3-羧基苯硼酸经Suzuki偶联得3'-硝基-2'-苄氧基联苯-3-羧酸,最后在钯炭催化下氢化和脱苄基得艾曲波帕中间体3'-氨基-2'-羟基联苯-3-羧酸,总收率71%。 6-Bromo-2-nitrophenol was subjected to benzyl protection to give 2-benzyloxy-l-bromo-3-nitrobenzene, which was further treated with 3-carboxyphenylboronic acid to afford 2’-benzyloxy-3’-nitro-[1,1’-biphenyl]-3-carboxylic acid via Suzuki coupling reaction. Subsequent hydrogenation with Pd/C catalysis provided the desired 3’-amino-2’-hydroxy-[1,1’-biphenyl]-3-carboxylic acid which was an key intermediate in the synthesis of eltrombopag with an overall yield of 71%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第12期1123-1124,共2页 Chinese Journal of Pharmaceuticals
关键词 3’-氨基-2’-羟基联苯-3-羧酸 艾曲波帕 血小板生成素受体激动剂 中间体 合成 3’-amino-2’-hydroxy-[1,1’-biphenyl]-3-carboxylic acid eltrombopag thrombopoitin(TPO) receptor agonist intermediate synthesis
  • 相关文献

参考文献6

  • 1US FDA.Eltrombopag[EB/OL].[2014-6-11].http://www.fda.gov/AboutFDA/CentersO ffices/OfficeofMedicalProducts andTobacco/CDER/ucm 129214.htm.
  • 2Duffy KJ,Erickson-Miller C,Jenkins J,et al.Thrombopoietin mimetics:US,20070129338A1[P].2007-07-07.
  • 3Süssmeier F,Lobell M,Grünewald S,et al.Substituted phenylimidazopyrazoles and their use:US,20130190290[P].2013-07-25.
  • 4Yamaguchi Y,Yanase T,Itai A,et al.Halogenated alkylsulfonamide derivative:WO,2011043456[P].2011-04-14.
  • 5Akwabi-Ameyaw A,Bass JY,Caldwell RD,et al.FXR agonist activity of conformationally constrained analogs of GW 4064[J].Bioorg Med Chem Lett,2009,19 (16):4733-4739.
  • 6Avdagic A,Baran PS.Processes for the preparation of an intermediate in the synthesis of eltrombopag:WO,2013049605[P].2013-04-04.

同被引文献16

  • 1Gamock-Jones KP, Keam SJ. Eltrombopag [J]. Drugs, 2009, 69 (5) : 567-576.
  • 2McHutchison JG, Dusheiko G, Shiffman ML, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C [J]. N Engl J Med, 2007, 357 (22) : 2227-2236.
  • 3邓炳初,吕贺军,费浩博,等.双环取代吡唑酮偶氮类衍生物、其制备方法及其在医药上的应用:中国,102159217[P].2011-08-17.
  • 4Marti BS, Joan Gabriel SR, Jacobo CC, et al. Preparation process of an agonist of the thrombopoietin receptor: EP, 2799425 [P]. 2014-11-05.
  • 5Avdagic A, Baran PS. Processes for the preparation of an intermediate in the synthesis of eltrombopag: WO, 2013049605 [P]. 2013-04-04.
  • 6Ermis DS, Mcmanus J, Wood-Kaczmar W, et al. Multikilo- gram-Scale synthesis of a biphenyl carboxylic acid derivative using a Pd/C-mediated Suzuki coupling approach [J]. Org Proc Res Dev, 1999, 3 (4) : 248-252.
  • 7Kohn M, Krasso O. The preparation of tetrahalogenated α-anisidines [J]. JOrg Chem, 1946, 11 (6) : 641-645.
  • 8US FDA. Eltrombopag [EB/OL]. [2014-06-11]. http:// www. fda.gov/AboutFDA/Centerso ffiees/OfficeofMedical ProduetsandT0bacco/CDER/ucm129214.htm.
  • 9邓炳初,吕贺军.双环取代吡唑酮偶氮类衍生物、其制备方法及其在医药上的应用:中国,101481352[P].2009-07-15.
  • 10Avdagic A, Baran PS. Process for the preparation of an intermediate in the synthesis of eltrombopag: WO, 2013049605 [P]. 2013-04-04.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部